M. tuberculosis Central Assian Strain 1 MDR isolates have more mutations in rpoB and katG genes compared with other genotypes

Scandinavian Journal of Infectious Diseases

Volumn 41, Issue 1, 2009, Pages 37-44

  Ali, Asho ^a   Hasan, Zahra ^a   Moatter, Tariq ^a   Tanveer, Mahnaz ^a   Hasan, Rumina ^a  

^a AGA KHAN UNIVERSITY   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; ETHAMBUTOL; INHA PROTEIN; ISONIAZID; KATG PROTEIN; PYRAZINAMIDE; RIFAMPICIN; RNA POLYMERASE BETA SUBUNIT; STREPTOMYCIN; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CODON; CONTROLLED STUDY; DNA SEQUENCE; FLUORESCENCE RESONANCE ENERGY TRANSFER; GENE MUTATION; GENOTYPE; MULTIDRUG RESISTANCE; MUTATIONAL ANALYSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PAKISTAN; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; STRAIN DIFFERENCE;

ANTITUBERCULAR AGENTS; BACTERIAL PROTEINS; CATALASE; DNA PROBES; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FLUORESCENCE RESONANCE ENERGY TRANSFER; GENOTYPE; HUMANS; ISONIAZID; MICROBIAL SENSITIVITY TESTS; MUTATION; MYCOBACTERIUM TUBERCULOSIS; PAKISTAN; POLYMERASE CHAIN REACTION; RIFAMPIN; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS, DNA; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY;

EID: 58049202242     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.1080/00365540802570519     Document Type: Article

References (43)

1. Espinal, MA, Laszlo, A., Simonsen, L., Boulahbal, F., Kim, SJ Reniero, A. et al. (2001) Global trends in resistance to anti-tuberculosis drugs. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance. N Engl J Med, 344, pp. 1294-1303.
2. (2006) XDR-TB: A global threat. Lancet, 368, p. 964.
3. WHO, R (2008) World Health Organization report: Global tuberculosis control.
4. Javaid, A., Hasan, R., Zafar, A., Ghafoor, A., Pathan, AJ Rab, A. et al. (2008) Prevalence of primary multidrug resistance to anti-tuberculosis drugs in Pakistan. Int J Tuberc Lung Dis, 12, pp. 326-331.
5. Irfan, S., Hassan, Q. and Hasan, R. (2006) Assessment of resistance in multidrug-resistant tuberculosis patients. J Pak Med Assoc, 56, pp. 397-400.
6. Butt, T., Ahmad, RN, Kazmi, SY and Rafi, N. (2004) Multidrug-resistant tuberculosis in northern Pakistan. J Pak Med Assoc, 54, pp. 469-472.
7. Hasan, Z., Tanveer, M., Kanji, A., Hasan, Q., Ghebremichael, S. and Hasan, R. (2006) Spoligotyping of Mycobacterium tuberculosis isolates from Pakistan reveals predominance of Central Asian Strain1 and Beijing isolates. J Clin Microbiol, 44, pp. 1763-1768.
8. Glynn, JR, Whiteley, J., Bifani, PJ, Kremer, K. and van Soolingen, D. (2002) Worldwide occurrence of Beijing/W strains of Mycobacterium tuberculosis: A systematic review. Emerg Infect Dis, 8, pp. 843-849.
9. Sreevatsan, S., Pan, X., Stockbauer, KE, Connell, ND, Kreiswirth, BN Whittam, TS et al. (1997) Restricted structural gene polymorphism in the Mycobacterium tuberculosis complex indicates evolutionarily recent global dissemination. Proc Natl Acad Sci U S A, 94, pp. 9869-9874.
10. Banerjee, A., Dubnau, E., Quemard, A., Balasubramanian, V., Um, KS Wilson, T. et al. (1994) inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis. Science, 263, pp. 227-230.
11. Zhang, Y., Heym, B., Allen, B., Young, D. and Cole, S. (1992) The catalase-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis. Nature, 358, pp. 591-593.
12. Lipin, MY, Stepanshina, VN, Shemyakin, IG and Shinnick, TM. (2007) Association of specific mutations in katG, rpoB, rpsL and rrs genes with spoligotypes of multidrug-resistant Mycobacterium tuberculosis isolates in Russia. Clin Microbiol Infect, 13, pp. 620-626.
13. Rossau, R., Traore, H., de Beenhouwer, H., Mijs, W., Jannes, G. de Rijk, P. et al. (1997) Evaluation of the INNO-LiPA Rif. TB assay, a reverse hybridization assay for the simultaneous detection of Mycobacterium tuberculosis complex and its resistance to rifampin. Antimicrob Agents Chemother, 41, pp. 2093-2098.
14. Suresh, N., Singh, UB, Arora, J., Pant, H., Seth, P. Sola, C. et al. (2006) rpoB gene sequencing and spoligotyping of multidrug-resistant Mycobacterium tuberculosis isolates from India. Infect Genet Evol, 6, pp. 474-483.
15. Sajduda, A., Brzostek, A., Poplawska, M., Augustynowicz-Kopec, E., Zwolska, Z. Niemann, S. et al. (2004) Molecular characterization of rifampin- and isoniazid-resistant Mycobacterium tuberculosis strains isolated in Poland. J Clin Microbiol, 42, pp. 2425-2431.
16. Torres, MJ (2002) Rapid detection of resistance associated mutations in Mycobacterium tuberculosis by Light Cycler PCR. Rapid cycle real-time PCR: Methods and applications, pp. 83-91.
17. Varma-Basil, M., El-Hajj, H., Colangeli, R., Hazbon, MH, Kumar, S. Bose, M. et al. (2004) Rapid detection of rifampin resistance in Mycobacterium tuberculosis isolates from India and Mexico by a molecular beacon assay. J Clin Microbiol, 42, pp. 5512-5516.
18. Isenberg, HD. (2004) Clinical Microbiology Procedure Handbook, 2, ASM press
19. Honore-Bouakline, S., Vincensini, JP, Giacuzzo, V., Lagrange, PH and Herrmann, JL. (2003) Rapid diagnosis of extrapulmonary tuberculosis by PCR: Impact of sample preparation and DNA extraction. J Clin Microbiol, 41, pp. 2323-2329.
20. Ma, X., Wang, H., Deng, Y., Liu, Z., Xu, Y. Pan, X. et al. (2006) rpoB gene mutations and molecular characterization of rifampin-resistant Mycobacterium tuberculosis isolates from Shandong Province, China. J Clin Microbiol, 44, pp. 3409-3412.
21. Ahmad, S., Fares, E., Araj, GF, Chugh, TD and Mustafa, AS. (2002) Prevalence of S315T mutation within the katG gene in isoniazid-resistant clinical Mycobacterium tuberculosis isolates from Dubai and Beirut. Int J Tuberc Lung Dis, 6, pp. 920-926.
22. Gonzalez, N., Torres, MJ, Aznar, J. and Palomares, JC. (1999) Molecular analysis of rifampin and isoniazid resistance of Mycobacterium tuberculosis clinical isolates in Seville, Spain. Tuber Lung Dis, 79, pp. 187-190.
23. Torres, MJ, Criado, A., Palomares, JC and Aznar, J. (2000) Use of real-time PCR and fluorimetry for rapid detection of rifampin and isoniazid resistance-associated mutations in Mycobacterium tuberculosis. J Clin Microbiol, 38, pp. 3194-3199.
24. Musser, JM. (1995) Antimicrobial agent resistance in mycobacteria: molecular genetic insights. Clin Microbiol Rev, 8, pp. 496-514.
25. Siddiqi, N., Shamim, M., Hussain, S., Choudhary, RK, Ahmed, N. Prachee et al. (2002) Molecular characterization of multidrug-resistant isolates of Mycobacterium tuberculosis from patients in northern India. Antimicrob Agents Chemother, 46, pp. 443-450.
26. Jiao, WW, Mokrousov, I., Sun, GZ, Li, M., Liu, JW Narvskaya, O. et al. (2007) Molecular characteristics of rifampin- and isoniazid-resistant Mycobacterium tuberculosis strains from Beijing, China. Chin Med J (Engl), 120, pp. 814-819.
27. Sharma, M., Sethi, S., Mishra, B., Sengupta, C. and Sharma, SK. (2003) Rapid detection of mutations in rpoB gene of rifampin-resistant Mycobacterium tuberculosis strains by line probe assay. Indian J Med Res, 117, pp. 76-80.
28. Afanas'ev, MV, Ikryannikova, LN, Il'ina, EN, Sidorenko, SV, Kuz'min, AV Larionova, EE et al. (2007) Molecular characteristics of rifampin- and isoniazid-resistant Mycobacterium tuberculosis isolates from the Russian Federation. J Antimicrob Chemother, 59, pp. 1057-1064.
29. Hirano, K., Abe, C. and Takahashi, M. (1999) Mutations in the rpoB gene of rifampin-resistant Mycobacterium tuberculosis strains isolated mostly in Asian countries and their rapid detection by line probe assay. J Clin Microbiol, 37, pp. 2663-2666.
30. Gagneux, S., Long, CD, Small, PM, Van, T., Schoolnik, GK and Bohannan, BJ. (2006) The competitive cost of antibiotic resistance in Mycobacterium tuberculosis. Science, 312, pp. 1944-1946.
31. Qian, L., Abe, C., Lin, TP, Yu, MC, Cho, SN Wang, S. et al. (2002) rpoB genotypes of Mycobacterium tuberculosis Beijing family isolates from East Asian countries. J Clin Microbiol, 40, pp. 1091-1094.
32. Yuen, LK, Leslie, D. and Coloe, PJ. (1999) Bacteriological and molecular analysis of rifampin-resistant Mycobacterium tuberculosis strains isolated in Australia. J Clin Microbiol, 37, pp. 3844-3850.
33. Telenti, A., Imboden, P., Marchesi, F., Lowrie, D., Cole, S. Colston, MJ et al. (1993) Detection of rifampin-resistant mutations in Mycobacterium tuberculosis. Lancet, 341, pp. 647-650.
34. Tracevska, T., Jansone, I., Baumanis, V., Marga, O. and Lillebaek, T. (2003) Prevalence of Beijing genotype in Latvian multidrug-resistant Mycobacterium tuberculosis isolates. Int J Tuberc Lung Dis, 7, pp. 1097-1103.
35. Heep, M., Brandstatter, B., Rieger, U., Lehn, N., Richter, E. Rusch-Gerdes, S. et al. (2001) Frequency of rpoB mutations inside and outside the cluster I region in rifampin-resistant clinical Mycobacterium tuberculosis isolates. J Clin Microbiol, 39, pp. 107-110.
36. Kapur, V., Li, LL, Hamrick, MR, Plikaytis, BB, Shinnick, TM Telenti, A. et al. (1995) Rapid Mycobacterium species assignment and unambiguous identification of mutations associated with antimicrobial resistance in Mycobacterium tuberculosis by automated DNA sequencing. Arch Pathol Lab Med, 119, pp. 131-138.
37. Ramaswamy, S. and Musser, JM. (1998) Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update. Tuber Lung Dis, 79, pp. 3-29.
38. Lavender, C., Globan, M., Sievers, A., Billman-Jacobe, H. and Fyfe, J. (2005) Molecular characterization of isoniazid-resistant Mycobacterium tuberculosis isolates collected in Australia. Antimicrob Agents Chemother, 49, pp. 4068-4074.
39. Wengenack, NL, Uhl, JR, St. Amand, AL, Tomlinson, AJ, Benson, LM Naylor, S. et al. (1997) Recombinant Mycobacterium tuberculosis KatG(S315T) is a competent catalase-peroxidase with reduced activity toward isoniazid. J Infect Dis, 176, pp. 722-727.
40. Baker, LV, Brown, TJ, Maxwell, O., Gibson, AL, Fang, Z. Yates, MD et al. (2005) Molecular analysis of isoniazid-resistant Mycobacterium tuberculosis isolates from England and Wales reveals the phylogenetic significance of the ahpC -46A polymorphism. Antimicrob Agents Chemother, 49, pp. 1455-1464.
41. Gagneux, S., Burgos, MV, de Riemer, K., Encisco, A., Munoz, S. Hopewell, PC et al. (2006) Impact of bacterial genetics on the transmission of isoniazid-resistant Mycobacterium tuberculosis. PLoS Pathog, 2, p. 61.
42. Pym, AS, Saint-Joanis, B. and Cole, ST. (2002) Effect of katG mutations on the virulence of Mycobacterium tuberculosis and the implication for transmission in humans. Infect Immun, 70, pp. 4955-4960.
43. Garcia de Viedma, D. (2003) Rapid detection of resistance in Mycobacterium tuberculosis: A review discussing molecular approaches. Clin Microbiol Infect, 9, pp. 349-359.